Italian scientists found standard drugs used to treat endometrial pain are enhanced when used in combination with estrogen and progestin hormone therapy. Gonadotropin-releasing hormone analogs are usually given to shrink tissue, but their use is limited to six months because of lowered estrogen levels and possible problems such as osteoporosis. The researchers said the hormone combination is sometimes given to stop bone-thinning and allow longer treatment.

Full Story:

Related Summaries